Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats

Anna J. Strachan, Trent M. Woodruff, Gerald Haaima, David P. Fairlie and Stephen M. Taylor
J Immunol June 15, 2000, 164 (12) 6560-6565; DOI: https://doi.org/10.4049/jimmunol.164.12.6560
Anna J. Strachan
*Department of Physiology and Pharmacology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trent M. Woodruff
*Department of Physiology and Pharmacology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald Haaima
†Drug, Design and Development Centre, University of Queensland, St. Lucia, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David P. Fairlie
†Drug, Design and Development Centre, University of Queensland, St. Lucia, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Taylor
*Department of Physiology and Pharmacology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    C5a and antagonist-binding affinity to rat and human PMNs. Rat PMNs were isolated from whole blood and incubated with 50 pM 125I-C5a in the presence of either C5a or AcF-[OPdChaWR]. Both C5a and antagonist inhibited binding of 125I-C5a binding to isolated PMNs to give a relative binding affinity value. IC50 values were obtained from each experiment and the means were determined. Data are shown as a percentage of maximal binding of 125I-C5a (mean ± SEM, n = 3–4).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Inhibition of C5a- and LPS-induced neutropenia and TNF-α expression with a C5a receptor antagonist. Intravenous C5a (2 μg/kg) or LPS (1 mg/kg) resulted in a rapid and transient neutropenia (A and B) and a significant increase in detectable circulating TNF-α (C and D). Pretreatment of rats with i.v. C5a receptor antagonist (1 mg/kg) inhibited neutropenia and elevated cytokine expression. Data are shown as means ± SEM (n = 3–6).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Reverse-passive Arthus-induced vascular leakage and cell migration. Initiation of a peritoneal Arthus reaction resulted in a significant increase in optical density (A), total cell number (B), and total PMN number (C) in the peritoneal lavage fluid 4 h after induction of immune complex formation. Data are shown for Ab, Ag, and antagonist control rats, Arthus-treated rats, and rats pretreated with antagonist (1 mg/kg i.v.) before initiation of a peritoneal Arthus reaction. The peritoneal cavity was lavaged 4 h after Arthus reaction induction, and total cell number was counted, the OD of the supernatant was recorded, and total PMN number was determined from a differential cell count. Data are shown as means ± SEM (n = 3–5). ∗, p ≤ 0.05 vs Ab control.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Time course of reverse-passive Arthus-induced elevated serum cytokine levels. Initiation of a peritoneal Arthus reaction resulted in significantly elevated serum TNF-α (A) and IL-6 (B) concentrations in the serum which had resolved within 4 h. Data are shown for Ab, Ag, and antagonist control rats, Arthus-treated rats, and rats pretreated with antagonist (1 mg/kg i.v.) before initiation of a peritoneal Arthus reaction. Serum was collected periodically over the 4-h treatment period, and serum cytokine levels were measured using ELISA. Data are shown as means ± SEM (n = 3–5). ∗, p ≤ 0.05 vs Ab control.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Reverse-passive Arthus-induced elevation of peritoneal cytokine levels. Initiation of a peritoneal Arthus reaction resulted in significantly elevated serum TNF-α (A) and IL-6 (B) concentrations in the peritoneal lavage fluid 4 h after induction of immune complex formation. Data are shown for the Ab, Ag, and antagonist control rats, Arthus-treated rats, and rats pretreated with antagonist (1 mg/kg i.v.) before initiation of a peritoneal Arthus reaction. The peritoneal cavity was lavaged 4 h after Arthus reaction induction, and cytokine levels were measured using ELISA. Data are shown as means ± SEM (n = 3–5). ∗, p ≤ 0.05 vs Ab control.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 164 (12)
The Journal of Immunology
Vol. 164, Issue 12
15 Jun 2000
  • Table of Contents
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats
Anna J. Strachan, Trent M. Woodruff, Gerald Haaima, David P. Fairlie, Stephen M. Taylor
The Journal of Immunology June 15, 2000, 164 (12) 6560-6565; DOI: 10.4049/jimmunol.164.12.6560

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats
Anna J. Strachan, Trent M. Woodruff, Gerald Haaima, David P. Fairlie, Stephen M. Taylor
The Journal of Immunology June 15, 2000, 164 (12) 6560-6565; DOI: 10.4049/jimmunol.164.12.6560
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Lung dysfunction in a mouse model of inflammation is dependent on T-cell-independent IL-13 expression (54.18)
  • TSG-6, a new protein ligand for CXCL8, modulates the activity of this pro-inflammatory chemokine (54.12)
  • Anti-inflammatory and anti-bacterial effect of polyacetylene compound from Cirsium japonicum var. ussuriense (54.19)
Show more Inflammation

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606